When Themis founder and CEO Neepa Patel set out to build a new compliance tool for banks, fintech startups, and crypto companies, she tapped into her own experience managing risk at some of the nation ...
PARIS — For patients with type 2 diabetes and stable coronary artery disease, the benefits of adding ticagrelor (Brilinta/Brilique, AstraZeneca) to aspirin in terms of reduced ischemic events did not ...
TTV Capital has led a $9m seed investment round in Themis, a collaborative governance, risk, and compliance platform. Other participating investors included Felicis and existing investors Walkabout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results